Seoul-based biotechnology company developing cancer treatments, including TCR-T cell therapies for solid tumors, antibodies and antibody-drug conjugates, T-cell engagers, immunotherapies, and small-molecule inhibitors
Seoul-based biotechnology company developing cancer treatments, including TCR-T cell therapies for solid tumors, antibodies and antibody-drug conjugates, T-cell engagers, immunotherapies, and small-molecule inhibitors. Its work includes oncology therapeutics and precision medicine.